SCHEMBL7658914

SCHEMBL7658914

NC(=O)OCCc1cccs1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
ALDH1A1 P00352 2/20 0.57
TSHR P16473 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
ADRA2A P08913 3/20 0.50
ADRA2B P18089 3/20 0.50
ADRA2C P18825 3/20 0.50
TAAR1 Q96RJ0 2/20 0.50
NPC1 O15118 4/20 0.49
LMNA P02545 1/20 0.46
CYP2C19 P33261 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
HPGD P15428 2/20 0.45
KDM4E B2RXH2 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7662082 0.90 SMN1; SMN2 (0.71) POLBSMN1; SMN2ALDH1A1TSHRL3MBTL1
SCHEMBL22691765 0.85 SMN1; SMN2 (0.53) POLBSMN1; SMN2ALDH1A1TSHRL3MBTL1
SCHEMBL28860065 0.84 NPC1 (0.54) POLBSMN1; SMN2ALDH1A1TSHRL3MBTL1
SCHEMBL3070804 0.82 SMN1; SMN2 (0.50) POLBSMN1; SMN2ALDH1A1TSHRL3MBTL1
SCHEMBL8684761 0.82 SMN1; SMN2 (0.50) POLBSMN1; SMN2ALDH1A1TSHRL3MBTL1
SCHEMBL1455603 0.81 POLB (0.53) POLBSMN1; SMN2ALDH1A1TSHRL3MBTL1
SCHEMBL7271233 0.80 SMN1; SMN2 (0.49) POLBSMN1; SMN2ALDH1A1TSHRL3MBTL1
SCHEMBL7271237 0.80 SMN1; SMN2 (0.49) POLBSMN1; SMN2ALDH1A1TSHRL3MBTL1
SCHEMBL20809605 0.79 SMN1; SMN2 (0.48) POLBSMN1; SMN2ALDH1A1TSHRL3MBTL1
SCHEMBL27683910 0.79 SMN1; SMN2 (0.55) POLBSMN1; SMN2ALDH1A1TSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101166733-A Pyrazole derivatives as phosphodiesterase 4 inhibitors MEMORY PHARM CORP (US) 2008-04-23 CN claimed
CN-111886233-B Triazolone derivatives or salts thereof and pharmaceutical compositions containing the same 柳韩洋行 2024-01-02 CN disclosed
CN-116437913-A Pharmaceutical compounds for treating complement-mediated disorders 艾其林医药公司 2023-07-14 CN disclosed
CN-115433160-B Analgesic active compounds and medical application thereof 中国人民解放军军事科学院军事医学研究院 2023-06-30 CN disclosed
CN-115433160-A Analgesic active compound and medical application thereof 中国人民解放军军事科学院军事医学研究院 2022-12-06 CN disclosed
CN-111886233-A Novel triazolone derivative or salt thereof and pharmaceutical composition comprising the same 柳韩洋行 2020-11-03 CN disclosed
CN-107108591-B Resorcinol derivatives as HSP90 inhibitors 正大天晴药业集团股份有限公司 2020-05-05 CN disclosed
CN-101166733-A Pyrazole derivatives as phosphodiesterase 4 inhibitors MEMORY PHARM CORP (US) 2008-04-23 CN disclosed
CN-1589153-A Prevention or treatment of urinary disorders TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2005-03-02 CN disclosed
US-6462076-B2 CYSTEINE PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CYSTEINE PROTEASES, SUCH AS OSTEOPOROSIS, OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, TUMOR METASTASIS, ANGINA PECTORIS, PLAQUE RUPTURE AND STROKE ETC. HOFFMANN-LA ROCHE INC. 2002-10-08 US disclosed